Search Within

Howard Scher

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (127)
  2. Meeting Abstract (71)
  3. Research Letter (2)
Groups
  1. Department of Medicine (200)
  2. Epidemiology and Biostatistics (200)
  3. Genitourinary Oncology Service (200)
  4. Solid Tumor Oncology Division (200)
  5. Biostatistics Service (159)
  6. GSK Faculty (108)

More Groups

People
  1. Glenn Heller (89)
  2. Michael Morris (66)
  3. Nikolaus Schultz (42)
  4. Daniel Danila (39)
  5. Steven Larson (38)
  6. David Solit (37)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (3)
  4. 2022 (8)
  5. 2021 (7)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (63)
  2. Clinical Cancer Research (23)
  3. Cancer Research (13)
  4. Urology (7)
  5. European Urology (6)
  6. Journal of Nuclear Medicine (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (66)
  2. American Association for Cancer Research (43)
  3. Elsevier Science, Inc. (19)
  4. Nature Publishing Group (14)
  5. Elsevier Inc. (7)
  6. Society of Nuclear Medicine (6)

More Publishers

Results (200)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumour lineage shapes BRCA-mediated phenotypes
    Research Letter

    Jonsson, P.; Bandlamudi, C.; Cheng, M. L.; Srinivasan, P.; Chavan, S. S.; Friedman, N. D.; Rosen, E. Y.; Richards, A. L.; Bouvier, N.; Selcuklu, S. D.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • Genomic correlates of clinical outcome in advanced prostate cancer
    Journal Article

    Abida, W.; Cyrta, J.; Heller, G.; Prandi, D.; Armenia, J.; Coleman, I.; Cieslik, M.; Benelli, M.; Robinson, D.; Van Allen, E. M.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2019)

    Fulltext@MSK | Save
  • Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade
    Journal Article

    Abida, W.; Cheng, M. L.; Armenia, J.; Middha, S.; Autio, K. A.; Vargas, H. A.; Rathkopf, D.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; more...
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • Clonal concordance and genomic heterogeneity in single CTC copy number alterations vs. paired IMPACT metastatic tissue sequencing from mCRPC patient samples
    Meeting Abstract

    Scher, H. I.; Dago, A. E.; Lee, J.; Sutton, R.; Graf, R. P.; Schreiber, N. A.; Hullings, M.; Wang, Y.; Landers, M. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 2, randomized, 3-arm study of abiraterone acetate and prednisone (AAP), AAP plus degarelix (AAP plus D), and degarelix (D) alone for patients (pts) with biochemically-recurrent prostate cancer (PC) following radical prostatectomy (RP)
    Meeting Abstract

    Autio, K. A.; Antonarakis, E. S.; Mayer, T. M.; Vaishampayan, U. N.; Shevrin, D. H.; Harrison, M. R.; Tagawa, S. T.; Milowsky, M. I.; Graff, J. N.; Beer, T. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Microsatellite instability in prostate cancer and response to immune checkpoint blockade
    Meeting Abstract

    Abida, W.; Cheng, M. L.; Armenia, J.; Middha, S.; Autio, K. A.; Rathkopf, D. E.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; Carbone, E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Estimation of tumor-derived mutant allele fractions in cfDNA by shallow whole genome sequencing and fragment size analysis
    Meeting Abstract

    Yang, J.; Marass, F.; Ulz, P.; Shady, M.; Cheng, M. L.; Kothari, P.; Gedvilaite, E.; Somnay, S.; Shukla, N.; Modak, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Kelly, D.; Devlin, S. M.; Coombs, C. C.; Moarii, M.; Patel, M.; Bernard, E.; Berthon, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Validation of nuclear-localized AR-V7 on circulating tumor cells (CTC) as a treatment-selection biomarker for managing metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Scher, H. I.; Graf, R. P.; Schreiber, N. A.; Winquist, E.; McLaughlin, B.; Lu, D.; Orr, S.; Fleisher, M.; Lowes, L.; Anderson, A. K. L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save